← Eichor
Condition: Metastatic Malignant Neoplasm In The Brain Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Metastatic Malignant Neoplasm In The Brain

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma
Phase 3 · 1 location(s) · Sun Yat-Sen University Cancer Center · NCT07058428Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases
NA · 10 location(s) · Susanne Rogers · NCT05124236Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT
Phase 3 · 1 location(s) · Tata Memorial Hospital · NCT05236946Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
Phase 2 · 1 location(s) · TYK Medicines, Inc · NCT0594881318F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
Phase 1 · 1 location(s) · Baptist Health South Florida · NCT06048094A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05419076Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
Phase 1/Phase 2 · 2 location(s) · Case Comprehensive Cancer Center · NCT01891318A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Phase 1 · 6 location(s) · Cogent Biosciences, Inc. · NCT07361562Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis
Phase 2 · 1 location(s) · University of Arizona · NCT06055790Motor Eloquent Navigated Transcranial Magnetic Stimulation for Radiosurgery Planning
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT07415668Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
Phase 3 · 4 location(s) · Mayo Clinic · NCT03750227Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
NA · 2 location(s) · Brigham and Women's Hospital · NCT04033497WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases
Phase 1/Phase 2 · 1 location(s) · Fudan University · NCT06243003Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX Metronomic Chemotherapy and Concurrent
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06839560a Feasibility Study of iHD-SRT for BM
NA · 1 location(s) · Ruijin Hospital · NCT06231186Sensitivity of Organoids to Predict Treatment Outcome in Breast Cancer Metastases
Phase N/A · 2 location(s) · King's College London · NCT06468124SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer
NA · 1 location(s) · The First People's Hospital of Lianyungang · NCT06476093A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT
Phase N/A · 2 location(s) · Chang Gung Memorial Hospital · NCT04805255Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis
Phase 1/Phase 2 · 1 location(s) · Fudan University · NCT06718933Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.
Phase 3 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07443397Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER
NA · 1 location(s) · QIAO LI · NCT07117864Evaluation of the CONVIVO System
NA · 1 location(s) · Dartmouth-Hitchcock Medical Center · NCT05139277Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors
Phase 2 · 1 location(s) · Samsung Medical Center · NCT07688356Development of MRF for Characterization of Brain Tumors After Radiotherapy
NA · 2 location(s) · Case Comprehensive Cancer Center · NCT06101069Study of Radiotherapy Combined With Platinum, Adebrelimab and Bevazumab in the Treatment of TNBC-BM.
Phase 2 · 1 location(s) · Fudan University · NCT07638852Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
Phase N/A · 1 location(s) · Duke University · NCT05480644ioMRI in the Surgery of Brain Metastases.
NA · 1 location(s) · Technical University of Munich · NCT071976327T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who De
Phase N/A · 1 location(s) · University of Missouri-Columbia · NCT07175077
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.